In head and neck cancer, where chronic inflammation is common, the crosstalk between NF-κB and the Hippo pathway contributes to cancer cell proliferation, migration, and immune evasion, providing a molecular basis for tumor progression and drug resistance. This evidence concerns the gene NFKB1 and neoplasm.